Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography

Published:2017-04-17 Issue:1 Volume:2 Page:
ISSN:2365-421X
Container-title:EJNMMI Radiopharmacy and Chemistry
language:en
Short-container-title:EJNMMI radiopharm. chem.

Author:

Dude Iulia,Zhang Zhengxing,Rousseau Julie,Hundal-Jabal Navjit,Colpo Nadine,Merkens Helen,Lin Kuo-Shyan,Bénard François

Funder

Canadian Breast Cancer Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Radiology, Nuclear Medicine and imaging,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1186/s41181-017-0023-y.pdf

Reference49 articles.

1. Alberini JL, Meunier B, Denzler B, Devillers A, Tass P, Dazord L, et al. Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiography. Breast Cancer Res Treat. 2000;61:21–32.

2. Bernhardt P, Kolby L, Johanson V, Nilsson O, Ahlman H, Forssell-Aronsson E. Biodistribution of 111in-DTPA-D-Phe1-octreotide in tumor-bearing nude mice: influence of amount injected and route of administration. Nucl Med Biol. 2003;30:253–60.

3. Bootsma AH, van Eijck C, Schouten KK, Reubi JC, Waser B, Foekens JA, et al. Somatostatin receptor-positive primary breast tumors: genetic, patient and tumor characteristics. Int J Cancer. 1993;54:357–62.

4. Cescato R, Waser B, Fani M, Reubi JC. Evaluation of 177Lu-DOTA-sst2 antagonist versus 177Lu-DOTA-sst2 agonist binding in human cancers in vitro. J Nucl Med. 2011;52:1886–90.

5. Ciocca DR, Puy LA, Fasoli LC, Tello O, Aznar JC, Gago FE, et al. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients. Breast Cancer Res Treat. 1990;15:175–84.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99mTc-maraciclatide in healthy volunteers;Nuclear Medicine Communications;2024-02-05

2. Perspektiven der PET-Radiopharmaka und Bildgebung: Von FDG bis FAPi, vom PETScanner zum digitalen Ganzkörpertool;PET/CT-Atlas;2024

3. The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years;Current Medical Imaging Formerly Current Medical Imaging Reviews;2023-07

4. Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist;Nuclear Medicine and Biology;2023-03

5. Assessment of Polycyclic Aromatic Hydrocarbons and Heavy Metal Pollutants in Soil Around Semi Urban Petrol Stations and Automobile Mechanic WorkshopsAssessment of Polycyclic Aromatic Hydrocarbons and Heavy Metal Pollutants in Soil Around Semi Urban Petrol Stations and Automobile Mechanic Workshops;Makara Journal of Science;2022-03-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3